Douglas Forsyth - 28 May 2025 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Role
Director
Signature
/s/ Kelly D. Deck, as attorney-in-fact for Douglas G. Forsyth
Issuer symbol
INBX
Transactions as of
28 May 2025
Transactions value $
$0
Form type
4
Filing time
29 May 2025, 16:24:59
Previous filing
26 Aug 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FORSYTH DOUGLAS Director C/O INHIBRX BIOSCIENCES, INC., 11025 NORTH TORREY PINES ROAD, SUITE 140, LA JOLLA /s/ Kelly D. Deck, as attorney-in-fact for Douglas G. Forsyth 29 May 2025 0001240801

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Award $0 +15K $0.00 15K 28 May 2025 Common Stock 15K $12.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option will be fully exercisable on May 28, 2026, subject to the reporting person's continued service through such date.